News

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's ...
SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ('IASO Bio'), a biopharmaceutical company focused on the discovery, development, manufacturing, and ...
The US Food and Drug Administration has granted accelerated approval to sunvozertinib (trade name Zegfrovy) from Dizal ...
US pharma giant seeks to expand footprint beyond cancer treatment as its biggest product nears patent cliff ...
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
The steady erosion of experienced staff is slowly compromising FDA work and low morale is pushing more workers to the exits ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
Safety in pharma manufacturing discussed at CII Telangana “Pillars of Protection” conference in Hyderabad: Shardul Nautiyal, Mumbai Wednesday, July 9, 2025, 08:00 Hrs [IST] Sa ...
China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, ...
WASHINGTON (AP) — The Trump administration has authorized providing $30 million to a U.S.- and Israeli-backed group that is distributing food in Gaza, a U.S. official said Tuesday, an operation ...
The bispecific antibody market is experiencing rapid growth, primarily driven by the increasing prevalence of complex chronic diseases, such as cance ...